HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Paul Modi Barnaby C. Reeves Andrew J. Parry Gianni D. Angelini Massimo Caputo Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Modi, P. Articles by Caputo, M. Search for Related Content PubMed PubMed Citation Articles by Modi, P. Articles by Caputo, M. Related Collections Congenital - acyanotic Congenital - cyanotic Myocardial protection

Eur J Cardiothorac Surg 2006;30:41-48
© 2006 Elsevier Science NL

Changes in myocardial free amino acids during pediatric cardiac surgery: a randomised controlled trial of three cardioplegic techniques

Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK

Received 14 November 2005; received in revised form 8 March 2006; accepted 10 March 2006.

^_* Corresponding author. Tel.: +44 117 928 2979; fax: +44 117 929 9737. (Email: m.caputo{at}bristol.ac.uk).

Objective: The developing heart has a much greater dependence on amino acid (AA) metabolism than the adult heart in determining its ischemic tolerance. Blood cardioplegia preserves myocardial free AAs in adult hearts but no clinical studies have looked at the effect of different cardioplegic techniques on intracellular free AAs in the pediatric heart. Methods: Pediatric patients were randomised to receive intermittent antegrade cold crystalloid (CC), cold blood (CB) or cold blood cardioplegia with a ‘hot shot’ (CB + HS). Right ventricular biopsies were collected prior to ischemia, at the end of ischemia and 20 min after reperfusion. Amino acid levels were analysed as repeated measures, adjusting for baseline levels. Data were analysed separately for acyanotic and cyanotic patients. Results: Of 103 patients recruited, 32 (22 acyanotic and 10 cyanotic), 36 (24/12) and 35 (25/10), respectively were allocated to CC, CB and CB + HS groups. Cyanotic patients were significantly younger with longer cross-clamp times. In acyanotic patients, there were no significant effects of cardioplegic method on aspartate, glutamine, taurine, alanine or branched chain AA levels (all p > 0.05). However, in cyanotic patients, there were significant interactions of cardioplegic method and time (all p < 0.05) for all amino acids, with patients allocated to CB + HS having higher levels after reperfusion compared with CC, and patients allocated to CB having intermediate levels. Conclusions: For cyanotic patients (younger, longer cross-clamp times), CB + HS preserves myocardial free AAs better than CC; CB gives an intermediate effect. In acyanotic patients, AA levels (all p > 0.15) and group means were similar both at the end of ischemia and after reperfusion.

Key Words: Cardioplegia • CHD • Cyanotic • CHD • Acyanotic • Ischemia/reperfusion • Pediatric • Surgery

This article has been cited by other articles:

				P. Sinha, D. Zurakowski, and R. A. Jonas Comparison of Two Cardioplegia Solutions Using Thermodilution Cardiac Output in Neonates and Infants Ann. Thorac. Surg., November 1, 2008; 86(5): 1613 - 1619. [Abstract] [Full Text] [PDF]